バイオロジクス受託開発の世界市場レポート 2025年

バイオロジクス受託開発の市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は11.4％で、131億9,000万米ドルに成長します。予測期間における成長の要因は、デジタル化とデータ分析、リスク管理、柔軟性と拡張性、研究開発への投資の急増、精密医療と個別化治療です。予測期間の世界の動向には、再生医療、リスク軽減戦略、世界な提携、先端技術、技術統合などが含まれます。

慢性疾患の増加は、今後数年間のバイオロジクス受託開発市場の成長を牽引すると予測されます。慢性疾患とは、1年以上続く病気で、継続的な治療が必要なものと定義されます。慢性疾患患者の増加は、生物学的製剤を含む新薬の開発需要の高まりにつながり、バイオロジクス受託開発市場を促進しています。例えば、英国の政府機関であるOffice for Health Improvement &Disparitiesの報告によると、2023年上半期の慢性下部呼吸器疾患による超過死亡者数は3,940人で、予想される死亡率に比べ30％増加しました。年末までにこの数字は5,363人に増加し、全体として22％の増加を反映しています。その結果、慢性疾患の蔓延がバイオロジクス受託開発市場の拡大を牽引することになります。

バイオ医薬品への投資の増加は、今後のバイオロジクス受託開発市場の成長を大きく後押しします。モノクローナル抗体、組換えタンパク質、遺伝子治療などのバイオ医薬品に対する需要の高まりは、企業が市場ニーズを満たすために開発活動をアウトソーシングすることを促しています。例えば、英国の製薬会社デロイトトウシュトーマツリミテッド（DTTL）が2024年4月に発表した報告書によると、バイオ医薬品分野の研究開発費の報告総額は、2022年の1,392億米ドルから2023年には1,455億米ドルに増加し、4.5%増となった。このため、バイオ医薬品への投資の拡大がバイオロジクス受託開発市場を牽引すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のバイオロジクス受託開発PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のバイオロジクス受託開発市場：成長率分析
• 世界のバイオロジクス受託開発市場の実績：規模と成長, 2019-2024
• 世界のバイオロジクス受託開発市場の予測：規模と成長, 2024-2029, 2034F
• 世界のバイオロジクス受託開発総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオロジクス受託開発市場：由来別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 微生物
• 哺乳類
• その他由来
• 世界のバイオロジクス受託開発市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 免疫疾患
• 心血管疾患
• 血液疾患
• その他適応症
• 世界のバイオロジクス受託開発市場：製品サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞株の開発
• プロセス開発
• その他製品サービス
• 世界のバイオロジクス受託開発市場：微生物のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細菌源
• 酵母源
• 真菌源
• 世界のバイオロジクス受託開発市場：哺乳類のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• チャイニーズハムスター卵巣（CHO）細胞
• ヒト胎児腎臓（HEK）細胞
• ハイブリドーマ細胞
• 世界のバイオロジクス受託開発市場：その他のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 植物ベースシステム
• 昆虫細胞システム
• 藻類源

第7章 地域別・国別分析

• 世界のバイオロジクス受託開発市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオロジクス受託開発市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオロジクス受託開発市場：競合情勢
• バイオロジクス受託開発市場：企業プロファイル
  • WuXi Biologics Overview, Products and Services, Strategy and Financial Analysis
  • Abzena Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Fujifilm Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis
  • KBI Biopharma Overview, Products and Services, Strategy and Financial Analysis
  • AGC Biologics Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Thermo Fisher Scientific Inc.
• LakePharma Inc.
• GenScript Biotech Corporation
• Bionova Scientific Inc.
• Boehringer Ingelheim GmbH
• STC Biologics
• Siegfried Evionnaz SA
• BioAgilytix Labs Inc.
• Samsung BioLogics
• Forge Biologics
• Lonza Group
• Catalent Inc.
• AbbVie Inc.
• Cytovance Biologics
• Emergent BioSolutions

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオロジクス受託開発市場2029：新たな機会を提供する国
• バイオロジクス受託開発市場2029：新たな機会を提供するセグメント
• バイオロジクス受託開発市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Biologics contract development involves companies that offer development and manufacturing services for biologics on a contractual basis to pharmaceutical firms. This outsourcing approach allows pharmaceutical companies to concentrate on marketing, research and development (R&D), and brand-building activities while entrusting the manufacturing of biologics to external service providers.

The primary sources for biologics contract development include microbial, mammalian, and other sources. Microbial sources are utilized in the production of various biologics. Biologics contract development caters to various indications, including oncology, immunological disorders, cardiovascular disorders, hematological disorders, and others. The product services offered in biologics contract development encompass cell line development, process development, and other related services.

The biologics contract development market research report is one of a series of new reports from The Business Research Company that provides biologics contract development market statistics, including biologics contract development industry global market size, regional shares, competitors with a biologics contract development market share, detailed biologics contract development market segments, market trends and opportunities, and any further data you may need to thrive in the biologics contract development industry. This biologics contract development market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biologics contract development market size has grown rapidly in recent years. It will grow from $7.75 billion in 2024 to $8.58 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to biologics market growth, rise in biopharmaceuticals, complexity of biologics, patent expirations, cost efficiency.

The biologics contract development market size is expected to see rapid growth in the next few years. It will grow to $13.19 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to digitalization and data analytics, risk management, flexibility and scalability, burgeoning investment in r&d, precision medicine and personalized therapies. Major trends in the forecast period include regenerative medicine, risk mitigation strategies, global collaborations, advanced technologies, technological integration.

The increasing prevalence of chronic diseases is projected to drive the growth of the biologics contract development market in the coming years. Chronic diseases are defined as illnesses lasting a year or longer that require ongoing medical attention. The rise in chronic disease cases is leading to a higher demand for the development of novel drugs, including biologics, thereby promoting the biologics contract development market. For instance, reports from the Office for Health Improvement & Disparities, a UK government body, indicated that in the first half of 2023, there were 3,940 excess deaths due to chronic lower respiratory diseases, representing a 30% increase compared to expected rates. By the end of the year, this figure rose to 5,363, reflecting an overall increase of 22%. Consequently, the growing prevalence of chronic diseases is set to drive the expansion of the biologics contract development market.

The rising investment in biopharmaceuticals is significantly fueling the growth of the biologics contract development market in the future. The increasing demand for biopharmaceuticals, such as monoclonal antibodies, recombinant proteins, and gene therapies, is prompting companies to outsource development activities to meet market needs. For example, a report published in April 2024 by Deloitte Touche Tohmatsu Limited (DTTL), a UK-based pharmaceutical company, indicated that total reported R&D spending in the biopharmaceutical sector rose from $139.2 billion in 2022 to $145.5 billion in 2023, representing a 4.5% increase. Therefore, the growing investment in biopharmaceuticals is expected to drive the biologics contract development market.

Technological advancements are reshaping the biologics contract development market, with major players incorporating advanced technologies to maintain their market standing. In January 2022, Lonza introduced the bYlok technology platform, designed to facilitate the design and manufacture of bispecific antibodies. This platform addresses challenges related to light-heavy chain mispairing, ensuring high yields, accuracy exceeding 95%, and compatibility with a monoclonal antibody (mAb)-like format. Technological innovation remains a focal point in sustaining competitiveness within the biologics contract development sector.

Major companies operating in the biologics contract development arena are integrating data analytics into their processes, fostering improved monitoring, analysis, and decision-making. This integration of digital technologies enhances efficiency and productivity in biologics development. In October 2022, Evotec SE launched PanHunter, part of the PanOmics data access and analytics technology, which enables advanced patient population stratification and prediction of efficacy and toxicity profiles. This incorporation of data analytics signifies a strategic move towards leveraging digital tools for enhanced insights in the biologics contract development market.

Strategic acquisitions play a pivotal role in reinforcing companies' positions in the biologics contract development market. In February 2022, Recipharm acquired Vibalogics and Arranta Bio, strengthening its presence in advanced therapy medicinal products and expanding virotherapy manufacturing capabilities in the US. Vibalogics and Arranta Bio, both contract development and manufacturing organizations, were pivotal acquisitions contributing to Recipharm's strategic growth in the biologics contract development sector.

Major companies operating in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc, LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., AbbVie Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Meridian Life Science Inc., Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Sartorius AG, Syngene International Limited, Vibalogics GmbH, Yposkesi

North America was the largest region in the biologics contract development market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biologics contract development market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biologics contract development market includes revenues earned by entities by sourcing, solid and specialized formulation development, and process analytics development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologics Contract Development Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics contract development market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics contract development ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics contract development market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Source: Microbial; Mammalian; Others Sources
• 2) By Indication: Oncology; Immunological Disorders; Cardiovascular Disorders; Hematological Disorders; Others Indications
• 3) By Product Service: Cell Line Development; Process Development; Others Product Services
• Subsegments:
• 1) By Microbial: Bacterial Sources; Yeast Sources; Fungal Sources
• 2) By Mammalian: Chinese Hamster Ovary (CHO) Cells; Human Embryonic Kidney (HEK) Cells; Hybridoma Cells
• 3) By Other Sources: Plant-Based Systems; Insect Cell Systems; Algal Sources
• Companies Mentioned: WuXi Biologics; Abzena Ltd.; Fujifilm Diosynth Biotechnologies; KBI Biopharma; AGC Biologics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biologics Contract Development Market Characteristics

3. Biologics Contract Development Market Trends And Strategies

4. Biologics Contract Development Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Biologics Contract Development Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biologics Contract Development PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biologics Contract Development Market Growth Rate Analysis
• 5.4. Global Biologics Contract Development Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biologics Contract Development Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biologics Contract Development Total Addressable Market (TAM)

6. Biologics Contract Development Market Segmentation

• 6.1. Global Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microbial
• Mammalian
• Others Soruces
• 6.2. Global Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Immunological disorders
• Cardiovascular disorders
• Hematological disorders
• Others Indications
• 6.3. Global Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Line Development
• Process Development
• Others Product Services
• 6.4. Global Biologics Contract Development Market, Sub-Segmentation Of Microbial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Sources
• Yeast Sources
• Fungal Sources
• 6.5. Global Biologics Contract Development Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chinese Hamster Ovary (CHO) Cells
• Human Embryonic Kidney (HEK) Cells
• Hybridoma Cells
• 6.6. Global Biologics Contract Development Market, Sub-Segmentation Of Other Sources, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plant-Based Systems
• Insect Cell Systems
• Algal Sources

7. Biologics Contract Development Market Regional And Country Analysis

• 7.1. Global Biologics Contract Development Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biologics Contract Development Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biologics Contract Development Market

• 8.1. Asia-Pacific Biologics Contract Development Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biologics Contract Development Market

• 9.1. China Biologics Contract Development Market Overview
• 9.2. China Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biologics Contract Development Market

• 10.1. India Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biologics Contract Development Market

• 11.1. Japan Biologics Contract Development Market Overview
• 11.2. Japan Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biologics Contract Development Market

• 12.1. Australia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biologics Contract Development Market

• 13.1. Indonesia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biologics Contract Development Market

• 14.1. South Korea Biologics Contract Development Market Overview
• 14.2. South Korea Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biologics Contract Development Market

• 15.1. Western Europe Biologics Contract Development Market Overview
• 15.2. Western Europe Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biologics Contract Development Market

• 16.1. UK Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biologics Contract Development Market

• 17.1. Germany Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biologics Contract Development Market

• 18.1. France Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biologics Contract Development Market

• 19.1. Italy Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biologics Contract Development Market

• 20.1. Spain Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biologics Contract Development Market

• 21.1. Eastern Europe Biologics Contract Development Market Overview
• 21.2. Eastern Europe Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biologics Contract Development Market

• 22.1. Russia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biologics Contract Development Market

• 23.1. North America Biologics Contract Development Market Overview
• 23.2. North America Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biologics Contract Development Market

• 24.1. USA Biologics Contract Development Market Overview
• 24.2. USA Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biologics Contract Development Market

• 25.1. Canada Biologics Contract Development Market Overview
• 25.2. Canada Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biologics Contract Development Market

• 26.1. South America Biologics Contract Development Market Overview
• 26.2. South America Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biologics Contract Development Market

• 27.1. Brazil Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biologics Contract Development Market

• 28.1. Middle East Biologics Contract Development Market Overview
• 28.2. Middle East Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biologics Contract Development Market

• 29.1. Africa Biologics Contract Development Market Overview
• 29.2. Africa Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biologics Contract Development Market Competitive Landscape And Company Profiles

• 30.1. Biologics Contract Development Market Competitive Landscape
• 30.2. Biologics Contract Development Market Company Profiles
  • 30.2.1. WuXi Biologics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abzena Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Fujifilm Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. KBI Biopharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AGC Biologics Overview, Products and Services, Strategy and Financial Analysis

31. Biologics Contract Development Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. LakePharma Inc.
• 31.3. GenScript Biotech Corporation
• 31.4. Bionova Scientific Inc.
• 31.5. Boehringer Ingelheim GmbH
• 31.6. STC Biologics
• 31.7. Siegfried Evionnaz SA
• 31.8. BioAgilytix Labs Inc.
• 31.9. Samsung BioLogics
• 31.10. Forge Biologics
• 31.11. Lonza Group
• 31.12. Catalent Inc.
• 31.13. AbbVie Inc.
• 31.14. Cytovance Biologics
• 31.15. Emergent BioSolutions

32. Global Biologics Contract Development Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biologics Contract Development Market

34. Recent Developments In The Biologics Contract Development Market

35. Biologics Contract Development Market High Potential Countries, Segments and Strategies

• 35.1 Biologics Contract Development Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biologics Contract Development Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biologics Contract Development Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer